Cytecare Hospitals, renowned for their comprehensive cancer treatment, has joined forces with ImmunoACT to bring cutting-edge CAR-T cell therapy to the state. This marks a significant milestone, making Cytecare the first in Karnataka to offer this potentially life-saving treatment outside of clinical trials.
This revolutionary treatment involves extracting a patient’s T-cells, modifying them to recognise and attack cancer cells, and then reinfusing them into the body. For patients with specific blood cancers like B-cell lymphoma and B-ALL, CAR-T cell therapy offers hope where conventional treatments may have failed. This personalised approach has shown remarkable success in improving quality of life and survival rates globally.
This collaboration opens a door of opportunity for patients in Karnataka battling blood cancers. With increased access and potentially lower costs, more patients can now benefit from this groundbreaking treatment.
Take a Look at these News Articles about Cytecare being the first hospital in Karnataka to offer CAR-T Cell Therapy.
ETHealthworld
![CAR-T Cell Therapy - ETHealthworlsd](https://cytecare.com/wp-content/uploads/2024/02/ETHealthworld11.png)
Click here for the full article
IndiaMedToday
![IndiaMedToday CAR-T Cell Therapy](https://cytecare.com/wp-content/uploads/2024/02/IndiaMedToday11.png)
Click here for the full article
PharmaBiz
![PharmaBiz CAR-T Cell Therapy](https://cytecare.com/wp-content/uploads/2024/02/Pharmabiz11.png)
Click here for the full article